Bicycle Therapeutics PLC
BCYCFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Bicycle Therapeutics PLC Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 9 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Apr 6, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| MORGAN STANLEY | 2026-03-31 | 618,327 | $2.87M | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 1,016 | $4.71K | SEC filing |
| GSK plc | 2026-03-31 | 1,529,561 | $7.1M | SEC filing |
| GSA CAPITAL PARTNERS LLP | 2026-03-31 | 26,842 | Not shown | SEC filing |
| TWO SIGMA SECURITIES, LLC | 2026-03-31 | 10,879 | $50.5K | SEC filing |
| Persistent Asset Partners Ltd | 2026-03-31 | 120,437 | $559K | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 278,992 | $1.29M | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 2,357 | $10.9K | SEC filing |
| DAFNA Capital Management LLC | 2026-03-31 | 64,492 | $299K | SEC filing |
| XTX Topco Ltd | 2026-03-31 | 106,392 | $494K | SEC filing |
| CITADEL ADVISORS LLC | 2026-03-31 | 377,085 | $1.75M | SEC filing |
| Erste Asset Management GmbH | 2026-03-31 | 14,000 | $60.8K | SEC filing |
| FNY Investment Advisers, LLC | 2026-03-31 | 7,557 | Not shown | SEC filing |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 2026-03-31 | 10,116 | $46.9K | SEC filing |
| HighMark Wealth Management LLC | 2026-03-31 | 435 | $2.02K | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 6 | $28 | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 979,300 | $4.54M | SEC filing |
| PRINCIPAL FINANCIAL GROUP INC | 2026-03-31 | 1,174,625 | $5.45M | SEC filing |
| State of New Jersey Common Pension Fund D | 2026-03-31 | 20,105 | $93.3K | SEC filing |
| BAKER BROS. ADVISORS LP | 2026-03-31 | 10,885,357 | $50.5M | SEC filing |
- Each value is checked against Bicycle Therapeutics PLC's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Bicycle Therapeutics PLC's share price.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Eversept Partners, LP: 178,915 shares reported 2025-12-31; 190,715 shares reported 2026-03-31.
- ASSETMARK, INC: 3,628 shares reported 2025-12-31; 4,218 shares reported 2026-03-31.
- Federation des caisses Desjardins du Quebec: 14,302 shares reported 2025-12-31; 14,302 shares reported 2026-03-31.
- SILVERCREST ASSET MANAGEMENT GROUP LLC: 476,976 shares reported 2025-12-31; 428,684 shares reported 2026-03-31.
- SUSQUEHANNA INTERNATIONAL GROUP, LLP: 108,423 shares reported 2025-12-31; 37,888 shares reported 2026-03-31.
- MANUFACTURERS LIFE INSURANCE COMPANY, THE: 127,863 shares reported 2025-12-31; 127,863 shares reported 2026-03-31.
- Winch Advisory Services, LLC: 172 shares reported 2025-12-31; 172 shares reported 2026-03-31.
- Invesco Ltd.: 10,092 shares reported 2025-12-31; 15,067 shares reported 2026-03-31.
- Jump Financial, LLC: 31,000 shares reported 2025-12-31; 52,544 shares reported 2026-03-31.
- Rockefeller Capital Management L.P.: 5 shares reported 2025-12-31; 5 shares reported 2026-03-31.
- Mirae Asset Global Investments Co., Ltd.: 2,248 shares reported 2025-12-31; 2,417 shares reported 2026-03-31.
- Rangeley Capital, LLC: 132,000 shares reported 2025-12-31; 232,260 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
82 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Bicycle Therapeutics PLC's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-04-02 · Lee Kevin: Larger than 117 of the 121 other insider sales of Ordinary Shares on file. SEC filing
- 2026-01-05 · Lee Kevin: Larger than all 121 other insider sales of Ordinary Shares on file. SEC filing
- 2026-01-05 · Milnes Alistair: Larger than 113 of the 121 other insider sales of Ordinary Shares on file. SEC filing
- 2026-01-05 · Skynner Michael: Larger than 110 of the 121 other insider sales of Ordinary Shares on file. SEC filing
- 2026-01-02 · Young Alethia: Larger than 112 of the 121 other insider sales of Ordinary Shares on file. SEC filing
- 2026-01-02 · Milnes Alistair: Larger than 109 of the 121 other insider sales of Ordinary Shares on file. SEC filing
- 2026-01-02 · Lee Kevin: Larger than 120 of the 121 other insider sales of Ordinary Shares on file. SEC filing
- 2025-04-03 · Lee Kevin: Larger than 114 of the 121 other insider sales of Ordinary Shares on file. SEC filing
- 2025-01-02 · Lee Kevin: Larger than 119 of the 121 other insider sales of Ordinary Shares on file. SEC filing
- 2025-01-02 · Milnes Alistair: Larger than 115 of the 121 other insider sales of Ordinary Shares on file. SEC filing
- 2025-01-02 · Skynner Michael: Larger than 111 of the 121 other insider sales of Ordinary Shares on file. SEC filing
- 2025-01-02 · Arroyo Santiago: Larger than 116 of the 121 other insider sales of Ordinary Shares on file. SEC filing
- 2024-12-13 · BAKER JULIAN: Larger than all 9 other insider purchases of American Depositary Shares on file. SEC filing
- 2024-01-03 · Lee Kevin: Larger than 118 of the 121 other insider sales of Ordinary Shares on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-04-06 | Hannay Michael Charles Ferguson · CHIEF PROD & SUPPLY CHAIN OFF | Ordinary Shares | S — Open market or private sale | −251 | 5.05 | SEC filing |
| 2026-04-06 | Perry Jennifer Scott · Chief Operating Officer | Ordinary Shares | S — Open market or private sale | −333 | 5.04 | SEC filing |
| 2026-04-06 | Perry Jennifer Scott · Chief Operating Officer | Ordinary Shares | S — Open market or private sale | −37 | 5.05 | SEC filing |
| 2026-04-06 | Lee Kevin · CHIEF EXECUTIVE OFFICER | Ordinary Shares | S — Open market or private sale | −1,716 | 5.05 | SEC filing |
| 2026-04-06 | Skynner Michael · CHIEF SCIENTIFIC OFFICER | Ordinary Shares | S — Open market or private sale | −525 | 5.05 | SEC filing |
| 2026-04-06 | Thompson Travis Alvin · Chief Financial Officer | Ordinary Shares | S — Open market or private sale | −102 | 5.05 | SEC filing |
| 2026-04-02 | Skynner Michael · CHIEF SCIENTIFIC OFFICER | Ordinary Shares | S — Open market or private sale | −1,879 | 4.91 | SEC filing |
| 2026-04-02 | Perry Jennifer Scott · Chief Operating Officer | Ordinary Shares | S — Open market or private sale | −1,038 | 4.91 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-02-03 | Thompson Travis Alvin · Chief Financial Officer | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +58,000 | SEC filing |
| 2026-01-02 | Sands Stephen H. · Director | Ordinary Shares | A — Grant, award, or other acquisition | +9,500 | SEC filing |
| 2026-01-02 | Swanton Robert Charles · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +7,453 | SEC filing |
| 2026-01-02 | Hannay Michael Charles Ferguson · CHIEF PROD & SUPPLY CHAIN OFF | Ordinary Shares | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-01-02 | Milnes Alistair · CHIEF OPERATING OFFICER | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +100,000 | SEC filing |
| 2026-01-02 | Bourque Janice · Director | Ordinary Shares | A — Grant, award, or other acquisition | +9,500 | SEC filing |
| 2026-01-02 | Riva Alessandro · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +14,761 | SEC filing |
| 2026-01-02 | BAKER JULIAN · Director, 10% owner | American Depositary Shares | A — Grant, award, or other acquisition | +19,000 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.